ABOUT
R&D PHARMA
2001
Founded in 2001 and headquartered in the Principality of Monaco, R&D Pharma is an independent, human-sized pharmaceutical laboratory dedicated to the responsible development and commercialization of therapeutic solutions.
ORGANIZATION
As a focused and agile organization, R&D Pharma combines regulatory expertise with close operational oversight, allowing for efficient decision-making and strong scientific engagement.
REGULATORY FRAMEWORK
Operating as a Marketing Authorization Holder (MAH) and holding exploitant status under French regulatory law, a framework that combines wholesale distribution authorization (WDA) with specific post-marketing obligations, the company oversees regulatory strategy, pharmacovigilance, product lifecycle management, and batch release activities for its authorized medicinal products.
MANUFACTURING & QUALITY
R&D Pharma holds the appropriate GMP authorization related to batch certification and release, enabling strengthened quality control and close collaboration with qualified GMP-compliant CDMO partners responsible for manufacturing.
Its marketed portfolio includes products such as Dolosof and Prosof across established therapeutic-areas.
Over time, the company has expanded into dermatology and technology-driven therapeutic approaches. Today, R&D Pharma develops and manufactures dermatological medical devices and advances investigational technologies through structured clinical evaluation programs.
LEADERSHIP
& TEAM
Our multidisciplinary team includes professionals with strong experience in:
- Clinical research
- Regulatory affairs
- Quality management
- Pharmaceutical affairs
- Medical device development
Join our
Team:
If you are interested by joining our agile and expert team,please contact us.